
---
title: '《狂犬病疫苗》9.狂犬病免疫球蛋白的应用'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705139'
author: 科学网
comments: false
date: Tue, 13 Apr 2021 06:36:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705139'
---

<div>   
<h2 style="margin: 15px 0 23px;text-indent: 46px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">大型学术专著《当代新疫苗》（第二版）于去年</span></strong><strong><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">3月正式出版。</span></strong></h2><h2 style="margin: 15px 0 23px;text-indent: 46px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px"><span style="font-family:KaiTi">本人与中国食品药品检定研究院的李玉华研究员共同撰写了该书第</span><span style="font-family:KaiTi">40章《狂犬病疫苗》。</span></span></strong></h2><h2 style="margin: 15px 0 23px;text-indent: 39px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">本博客将分若干次全文转载这一章的内容。今天转载的是本章的第</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">9</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">节</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">:</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">狂犬病</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">免疫球蛋白的应用</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 21px">。</span></strong></h2><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 29px"><span style="font-family:Microsoft YaHei UI">９</span><span style="font-family:Microsoft YaHei UI">. 狂犬病免疫球蛋白的应用</span></span></strong></p><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px"><span style="font-family:Microsoft YaHei UI">９</span><span style="font-family:Microsoft YaHei UI">.１. 狂犬病免疫球蛋白的适用对象</span></span></strong><strong>　　</strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ＷＨＯ建议，对于狂犬病病毒的</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">III</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">级暴露，即一处或多处皮肤的穿透性（出血性）咬伤或抓伤，或被可疑的疯动物的唾液污染黏膜，不仅应立即接种疫苗进行主动免疫，而且应同时在伤口周围浸润注射</span></strong><span style="text-decoration: underline;"><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">狂犬病免疫球蛋白</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">(rabies immunoglubulin, RIG)</span></strong></span><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">进行被动免疫，以获得快速的保护作用。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">头部、手部等神经密集分布的部位被咬伤，以及伤口较深或较多的病人最易被感染，最需要注射</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。虽然单独接种疫苗能够挽救大部分病人，但某些病人仍需要立即接受被动免疫才能够生还</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(Both et al.,2012)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">最近对</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">AIDS</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">病人的研究还表明，一些</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">CD4</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">细胞数量很低的病人疫苗免疫后中和抗体产生很慢或不产生。因此，ＷＨＯ狂犬病专家委员会建议，对免疫力低下的病人即使是</span><span style="font-family:KaiTi">Ⅱ级暴露也应联合应用</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG(Thisyakorn et al.,2000)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG通常</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">终生只能使用一次。再次暴露后只需加强接种疫苗</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">1</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">～</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">2</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">针，而不再需要接种</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px"><span style="font-family:Microsoft YaHei UI">９</span><span style="font-family:Microsoft YaHei UI">.２. </span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">RIG</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">的作用机制</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">是一种被动免疫制剂，主要含</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RVNA（狂犬病毒中和抗体）</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">。它无须机体应答，就能够立即以中和方式直接杀灭进入体内的狂犬病病毒。</span><span style="font-family:KaiTi">因此，在被疯动物咬伤的伤口周围立即注射</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">将提升针对狂犬病的保护水平。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的作用就是在疫苗通常能够诱导机体主动产生必要数量的抗体</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(7</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">天</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">之前，在患者的暴露部位立即提供被动保护。由于狂犬病是死亡率</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">100</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">％的高度致死性疾病，所以所有属于</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">WHO</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">定义为</span><span style="font-family:KaiTi">Ⅲ级的暴露病人，都应在穿透皮肤的伤口内或黏膜上使用</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">但</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">作用维持的时间不长，经过较短的半衰期就会降解或被机体清除，即</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">具有作用快速但短暂的特点。而疫苗产生作用虽然需要一定时间，但它诱生的抗体一旦开始产生，就能在较长时间内持续产生，并维持较长的时间，即具有持续性。</span><span style="font-family:KaiTi">所以狂犬病完整的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">PEP</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">措施包括结合使用疫苗和</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">；两者协同作用，才能提供全程的保护作用。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">图１显示</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的作用原理。</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">WHO</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">确认的抗狂犬病血清阳转标准为</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">0.5 IU/mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">，即血清中抗ＲＶ的抗体滴度达到</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">0.5 IU/mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">才说明具有足够的保护力。</span><span style="font-family:KaiTi">单纯注射疫苗通常至少要到</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">7</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">天以后才能获得足够的保护力，</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的作用就是填补第</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">0</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">～</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">7</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">天这个时间段保护力的空白，在这段时间即时提供保护作用（俞永新，</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">2009</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">）。</span></strong></p><p style="margin: 15px 0;text-indent: 0;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705139" title alt="image.png" width="742" height="358" style="width: 742px; height: 358px;" referrerpolicy="no-referrer"> </span></strong></p><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px"><span style="font-family:Microsoft YaHei UI">图１</span> <span style="font-family:Microsoft YaHei UI">CCRV暴露后免疫程序的第</span></span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">0</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">，</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">3</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">，</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">7</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">，</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">14</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">，</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">28</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">天及＞</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">28</span><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 1px;font-size: 16px">天RV抗体滴度的变化。</span></p><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px"><span style="font-family:Microsoft YaHei UI">９</span><span style="font-family:Microsoft YaHei UI">.３. </span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">RIG</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">的作用</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">目前常用的两种</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">为</span></strong><span style="text-decoration: underline;"><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">人狂犬病免疫球蛋白</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">(HRIG)</span></strong></span><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">和</span></strong><span style="text-decoration: underline;"><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">马狂犬病免疫球蛋白</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">(ERIG</span></strong></span><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">。</span> <span style="font-family:KaiTi">应优先选用</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">是经过严格筛选供体和清除病毒污染（包括人免疫缺陷病毒和肝炎病毒等）等处理后纯化而制成的，基本上不会引发严重副反应。</span> <span style="font-family:KaiTi">但由于</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">价格昂贵、供应不足，并不是所有需要的病人都能得到这种能够挽救生命的产品。</span><span style="font-family:KaiTi">马狂犬病免疫球蛋白（</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ERIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">）或其</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">F(ab</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">′</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">)2</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">片段产品在人体内的清除速度较快，但较易获得，且价格较低。大多数按新工艺生产的</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ERIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">制剂效价高、纯度高、安全，但它们对人体而言属于异源蛋白，仍有可能引起包括过敏性反应在内的严重不良反应（发生率为</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">1/4.5</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">万）；只有经过训练并有相应设备能处理此类副反应的医务人员，才能使用</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ERIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">和</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ERIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的优缺点比较见表</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">3</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 0;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">表</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">3</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">　人狂犬病免疫球蛋白</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(HRIG)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">和马狂犬病免疫球蛋白</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(ERIG)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的优缺点比较</span></strong></p><p style="margin: 15px 0;text-indent: 0;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705140" title alt="image.png" width="719" height="600" style="width: 719px; height: 600px;" referrerpolicy="no-referrer"></span></strong></p><p style="margin: 15px 0;text-indent: 0;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">９.４. </span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">RIG</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px">的使用方法</span></strong><br></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">在解剖学上可能的情况下（避免引发筋膜间隙综合征），所有的</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">应浸润式注射到被疯动物咬伤的伤口内或周围，以中和在咬伤时侵入并存在于组织中的狂犬病毒。尽量不要忽略任何微小的伤口</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(WHO,2010)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">终生只需注射一次，并应在</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">PEP</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">启动后尽快注射（首剂疫苗接种</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">7</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">天后不宜再注射</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">）。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">的最大使用剂量为</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">20 IU/kg</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">体重，</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">ERIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">和</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">F(ab</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">′</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">)2</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">片段产品的剂量则为</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">40 IU/kg</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">体重。</span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">应稀释至足够供所有伤口使用的量，以供安全有效地浸润。</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">RIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">要预先计划好，不要有剩余，不要在伤口以外部位使用。</span></strong></p><p style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #333333;letter-spacing: 1px;font-size: 21px"><span style="font-family:Microsoft YaHei UI">９</span><span style="font-family:Microsoft YaHei UI">.５. 单克隆抗体</span></span></strong></p><p style="margin: 15px 0;text-indent: 56px;padding: 0;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">人狂犬病免疫球蛋白</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(HRIG)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">或马狂犬病免疫球蛋白</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(ERIG)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">在发展中国家仍供应短缺或价格昂贵，或存在安全性问题，中和狂犬病毒的</span></strong><span style="text-decoration: underline;"><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">单克隆抗体</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 19px;">(monoclonal antibody,McAb</span></strong></span><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">可以在人－小鼠杂交细胞中生产，可能用于替代供应不足的</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px"><span style="font-family:KaiTi">。</span><span style="font-family:KaiTi">美国费城和美国</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">CDC</span></strong><strong><span style="line-height: 200%; letter-spacing: 0px; font-size: 19px; font-family: KaiTi;">的研究者创造了一种含3种单克隆抗体的混合制剂。</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">Crucell</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">公司研制了两种互补抗体，这两种抗体直接拮抗</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">G</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">蛋白上的两种抗原决定簇。两种抗体称为</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">CR57</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">和</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">CR4098</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">，联合用于叙利亚仓鼠检测其拮抗狂犬病的效果，并与</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">HRIG</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">对比。单克隆抗体高效地中和了</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">26</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">种狂犬病病毒，同时疫苗接种的免疫原性并没有受到抑制，结果保护了仓鼠免受强毒力狂犬病病毒的攻击</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;letter-spacing: 0;font-size: 19px">(Nagarajan et al.,2008)</span></strong><strong><span style="line-height: 200%; letter-spacing: 0px; font-size: 19px; font-family: KaiTi;">。中国华北制药公司获得的人源抗狂犬病毒单克隆抗体也进行了Ⅱ期临床试验。两种抗体联合应用也可以中和逃逸变异株。单克隆抗体可能很快就会进入商业用途。单克隆抗体在植物中表达为单链或双链抗体，可以降低生产成本。</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">相关博文：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:20px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1277395" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》专著共享</span></span></a><span style="font-family: SimSun;color: #6666CC;letter-spacing: 0;font-size: 19px"> </span><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2021-03-18</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:20px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1277585" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著共享) 1. 概述</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> </span><span style="font-family: SimSun;color: #666666;letter-spacing: 0;font-size: 19px"> </span><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px">2021-03-19</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:20px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1277814" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著共享) 2.病原学</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> </span><span style="font-family: SimSun;color: #666666;letter-spacing: 0;font-size: 19px"> </span><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px">2021-03-21</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:20px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1277951" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著共享) 3.流行病学</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2021-03-22</span><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1278323" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:29px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著) 4. 发病机理与疫苗免疫应答</span></strong><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2021-03-24</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:29px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1278633" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著) 5. 狂犬病的症状和临床诊断</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2021-03-26</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:29px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1279308" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705141" title alt="image.png" referrerpolicy="no-referrer">《狂犬病疫苗》</span>(专著) 6. 狂犬病疫苗制造(A)</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2021-03-30</span></p><p style="margin-left:0;text-indent:35px;text-autospace:ideograph-numeric;line-height:200%"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1279597" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著) 6. 狂犬病疫苗制造(B)</span></span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 19px;background: #FFFFFF"> 2021-04-01</span></p><p style="margin-left: 0px; text-indent: 35px; line-height: 200%;"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=705142" title alt="image.png" referrerpolicy="no-referrer"><a href="http://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1281048" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Tahoma">《狂犬病疫苗》</span>(专著) 7-8. 狂犬病暴露后和暴露前的预防</span></span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 19px;background: #FFFFFF"> 2021-04-09</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-347754-1281683.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-347754-1281683.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1281352.html" target="_black">用于治疗绦虫感染的药物可能用于治疗新冠肺炎？</a><br>                    <!--大赛结束-->
                                        
  
</div>
            